UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
Current Report Pursuant to Section 13 or 15 (d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): May 27, 2005
Bio Solutions Manufacturing, Inc.
- -------------------------------------------------------------------------------
(Exact Name of Registrant as Specified in its Charter)
New York
------------------------------------------------------------
(State or Other Jurisdiction of Incorporation)
000-33229 16-1576984
- ------------------------------------ ------------------------------
(Commission File Number) (I.R.S. Employer
Identification No.)
1161 James Street, Hattiesburg, MS 39401
------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
(601) 582-4000
------------------------------------------------------------
(Registrant's Telephone Number, Including Area Code)
------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
[_] Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425
[_] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR240.14a-12)
[_] Pre-commencement communications pursuant to Rule 14-2(b) under the Exchange
Act (17 CFR 240.14d- 2(b))
[_] Pre-commencement communications pursuant to Rule 13(e)-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
SECTION 1- REGISTRANT'S BUSINESS AND OPERATIONS
Not Applicable
SECTION 2 - FINANCIAL INFORMATION
Not Applicable
SECTION 3 - SECURITIES AND TRADING MARKETS
Not Applicable
SECTION 4 - MATTERS RELATED TO ACCOUNTANTS AND FINANCIAL INFORMATION
Not Applicable
SECTION 5 - CORPORATE GOVERNANCE AND MANAGEMENT
Item 5.02(a) Departure of Principal Officer
On May 25, 2004 the Company removed Michael O'Gorman as President and Chief
Executive Officer.
Item 5.02(b) Appointment of President and Chief Executive Officer
On May 27, 2005, the Board of Directors elected David S. Bennett as
President and Chief Executive Officer.
Mr. Bennett has over 25 years experience in direct sales and channel
partnerships, including IBM, Oracle and Sun Microsystems. Most recently, he has
acted as senior business development consultant for a number of specialty
start-up firms. He was Vice President and Head of North American Sales for OM
Technology, Inc., a European firm. He has generated over $50 million in software
license revenues from treasury and derivative applications from over 30 banks
and major financial institutions. From 1991 through 1997, as Head of Sales for
TCAM, a North American firm specializing in order management and equities
trading, Mr. Bennett brought the firm into the top 5% of software firms in the
United States, based upon both license and service bureau revenue streams. He
has both graduate and post graduate degrees in Economics and Education from
Southampton University, U.K.
Item 5.02 (c) Election of a New Director
On May 27, 2005, Robert J. Knorr, Jr. was elected to the Board of Directors
of the Company.
Mr. Knorr has more than 40 years experience in various aspects of corporate
and international marketing and finance. From 1968 until 1990, he was employed
by Johnson and Johnson or its subsidiaries in various positions ranging from
cost controller of a subsidiary to Vice-President of Finance for the
Professional Sector of the Company. While employed by Johnson and Johnson, his
responsibilities included the installation of a new standard cost system and
provided the manufacturing departments with new and upgraded systems to better
monitor operations, providing support to marketing in all aspects of finance,
coordination of financial activities for 15 consumer and industrial companies,
Chief Financial Officer of a 500 million dollar consumer products company where
he directed all financial and information technology and established major cost
improvement programs throughout the company generating at least 20 million
dollars per year in savings and the negotiation of joint ventures in Russia and
served as a consultant to the Vice Chairman for the professional sector. Since
1990, Mr. Knorr, as a partner in Prism Consulting, has established a consulting
company, found a new partner for Wrigley in Hungary and assisted other companies
in the development of their business plans.
SECTION 6 - [Reserved]
Not Applicable
SECTION 7 - REGULATION FD
Not Applicable
SECTION 8 - OTHER EVENTS
Not Applicable
SECTION 9 - FINANCIAL STATEMENTS AND EXHIBITS
None
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Bio Solutions Manufacturing, Inc.
(Registrant)
Date: June , 2005 By: /s/ David S. Bennett
----------------------------
David S. Bennett
Chief Executive Officer